Literature DB >> 8517665

Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines.

P Y Leung1, K Miyashita, M Young, C S Tsao.   

Abstract

The effect of L-ascorbate and its derivatives on the growth of malignant and nonmalignant cell lines has been examined. L-Ascorbate and its oxidative product dehydroascorbate were cytotoxic or lethal to the fast-growing malignant cells, but they were less toxic to nonmalignant cells. Two isomers of ascorbate, D-ascorbate and D-isoascorbate, both with 5% of the antiscorbutic potency and very high turnover rate, had similar activities. The cytotoxic effect of ascorbate was apparently not related to the metabolic or vitamin activities of ascorbate at the cellular level. Furthermore, studies on the viability of treated cells indicated that the observed effect on cell growth was not cytostatic in nature but was the result of a direct cell-killing action of ascorbate. Several groups of ascorbate derivatives were also tested; many of them were toxic to these cells. The results support the hypothesis that the cytotoxic activity of ascorbate was due to its chemical properties and that certain oxidation and degradation products of ascorbate were cytotoxic agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8517665

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  20 in total

1.  Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Authors:  Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

Review 2.  Unconventional therapies for cancer: 5. Vitamins A, C and E. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-06-02       Impact factor: 8.262

3.  Antioxidants and Other Micronutrients in Complementary Oncology.

Authors:  Uwe Gröber
Journal:  Breast Care (Basel)       Date:  2009-02-20       Impact factor: 2.860

4.  SVCT2 Is Expressed by Cerebellar Precursor Cells, Which Differentiate into Neurons in Response to Ascorbic Acid.

Authors:  Karina Oyarce; Carmen Silva-Alvarez; Luciano Ferrada; Fernando Martínez; Katterine Salazar; Francisco Nualart
Journal:  Mol Neurobiol       Date:  2017-01-17       Impact factor: 5.590

5.  Intravenously administered vitamin C as cancer therapy: three cases.

Authors:  Sebastian J Padayatty; Hugh D Riordan; Stephen M Hewitt; Arie Katz; L John Hoffer; Mark Levine
Journal:  CMAJ       Date:  2006-03-28       Impact factor: 8.262

6.  Molecular structure-dependent cytotoxic effect of ascorbate derivatives.

Authors:  C S Tsao; M Young
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-02       Impact factor: 2.416

7.  Synergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapy.

Authors:  Sensuke Konno
Journal:  Int J Gen Med       Date:  2009-07-30

Review 8.  Ascorbate on cell growth and differentiation.

Authors:  F J Alcaín; M I Burón
Journal:  J Bioenerg Biomembr       Date:  1994-08       Impact factor: 2.945

9.  Mitochondria, Energy and Cancer: The Relationship with Ascorbic Acid.

Authors:  Michael J González; Glorivee Rosario-Pérez; Angélica M Guzmán; Jorge R Miranda-Massari; Jorge Duconge; Julio Lavergne; Nadia Fernandez; Norma Ortiz; Ana Quintero; Nina Mikirova; Neil H Riordan; Carlos M Ricart
Journal:  J Orthomol Med       Date:  2010

10.  6-Amino-6-deoxyascorbic acid induces apoptosis in human tumor cells.

Authors:  M Grdisa; M Kralj; M Eckert-Maksić; Z B Maksić; K Pavelić
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.